Altered Expression of Nuclear Non-Histone Protein (P44/46) in Different Stages of B-Chronic Lymphocytic Leukemia

References

• Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pastemack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Binet J. L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchemia G., Jacquillat C., Boivin P. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Gardais J. Is there still a place for clinical staging in chronic lymphocytic leukemia?. Leukemia Research 1999; 23: 589–592
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Döhner K., Bentz M., Lichter P., Döhner H. Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Annals of Hematology 1998; 76: 101–110
   PubMed Web of Science ®Google Scholar
• Döhner H., Stilgenbauer S., Döhner K., Benitz M., Lichter P. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine 1999; 77: 266–281
   PubMed Web of Science ®Google Scholar
• Juliusson G., Oscier D. G., Fitchett M., Ross F. M., Stockdill G., Mackie M. J., Parker A. C., Castaldi G. L., Cuneo A., Knuutila S., Elonen E., Gahrton G. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosome abnormalities. New England Journal of Medicine 1990; 323: 720–724
   PubMed Web of Science ®Google Scholar
• Fitchett M., Griffiths M. J., Oscier D. G., Johnson S., Seabright M. Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genetics and Cytogenetics 1987; 24: 143–150
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath J. T., Knowles D. M., Della-Favera R. p53 mutations in human lymphoid malignancies association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N. Z., Filippa D. A., Louie D., Pan D., Jhanwar S. C., Dalla-Favera R., Chaganti R. S. K. 6q deletions define distinct clinicopathologic subsets on non-Hodkin's lymphoma. Blood 1993; 82: 2157–2162
   PubMed Web of Science ®Google Scholar
• Reed J. C. Molecular biology of chronic lymphocytic leukemia. Seminars in Oncology 1998; 25: 11–18
   PubMed Web of Science ®Google Scholar
• Pittman S., Catovsky D. Prognostic significance of chromosome abnormalities in patients with chronic lymphocytic leukemia. British Journal of Haematology 1984; 58: 649–660
   PubMed Web of Science ®Google Scholar
• Quesnel B., Preudhomme C., Philippe N., Vanrumbeke M., Dervite I., Lai J. L., Bauters F., Wattel E., Fenaux P. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995; 85: 657–663
   PubMed Web of Science ®Google Scholar
• Gazit Y., Polliack A. Characterization of GP-70: a novel B-cell leukemia specific antigen and the correlation between GP-70 expression and disease activity. Chronic Lymphocytic Leukemia, A. Polliack, D. Catovsky. Harwood Academic Publishers, Chur., London 1988; 67–84
   Google Scholar
• Saunders F. K., Lawry J., Winfield D. A., Goepel J. R., Hancock B. W., Sharrard R. M., Goyns M. H. Comparison of protein synthesis profiles in chronic lymphocytic leukemia cells and B-lymphocytes from peripheral blood, cord and tonsil. Experientia 1994; 50: 493–496
   PubMedGoogle Scholar
• Estaáol J. M., Agell N., Bachs O. Nuclear protein patterns in normal T-lymphocytes and lymphoblastoid cells. Cancer Research 1997; 57: 55–61
   PubMed Web of Science ®Google Scholar
• Marotta G., Raspadori D., Sestigani C., Scalia G., Bigazzi C., Lauria C. Expression of the CD11c antigen in B-cell chronic lymphoproliferative disorders. Leukemia and Lymphoma 2000; 37: 145–149
   PubMed Web of Science ®Google Scholar
• Chrusciel J., Błonski J., Krykowski E., Mirowski M., Hanausek M., Kiliaska Z. M. Characterization of proteins from chronic lymphocytic leukemia cells. Cytobios 1996; 85: 39–49
   PubMedGoogle Scholar
• Chruciel J., Błonski J., Szymczyk P., Robak T., Kiliaska Z. M. A novel B-CLL specific nuclear protein (p44/46). Leukemia Research 1999; 23: 833–841
   PubMed Web of Science ®Google Scholar
• Cheson B. D., Bennett J. M., Rai K. R., Grever M. R., Kay N. E., Schiffer C. A., Oken M. M., Keating M. J., Boldt D. H., Kempin S. J., Foon K. A. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute—sponsored Working Group. American Journal of Hematology 1988; 29: 152–163
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scandinavian Journal of Clinical Laboratory investigation 1968; 21: 77–89
   PubMed Web of Science ®Google Scholar
• Blobel G., Potter V. R. Nuclei from rat liver: isolation method that combines purity with high yield. Science 1966; 154: 1662–1665
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Wray W., Boulikas T., Wray V. P., Hancock R. Silver staining of proteins in polyacrylamide gels. Analytical Biochemistry 1981; 118: 197–203
   PubMed Web of Science ®Google Scholar
• Towbin H., Staechelin T., Gordon J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Leary J. J., Brigati J. J., Ward D. C. Rapid biotinla-belled DNA probes hybrized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proceedings of the National Academy of Sciences of Sciences of the United States of America 1983; 80: 4045–4049
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurements with the Folin phenol reagent. The Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Kroft S. H., Finn W. G., Peterson L. C. The pathology of the chronic lymphoid leukemias. Blood Reviews 1995; 9: 234–250
   PubMed Web of Science ®Google Scholar
• Criel A., Verhoef G., Vlietinck R., Mecucci C., Billiet J., Michaux L., Meeus P., Louwagie A., Van Orshoven A., van Hoof A., Boogaerts M., Van den Berghe H., De Wolf-Peeters C. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. British Journal of Haematology 1997; 97: 383–391
   PubMed Web of Science ®Google Scholar
• Del Gilgio A., O'Brien S., Ford R., Saya H., Manning J., Keating M., Johnston D., Khetan R., El-Naggar A., Deisseroth A. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. Blood 1992; 79: 2717–2720
   PubMed Web of Science ®Google Scholar
• Tötterman T., Nilsson K., Simonsson B. Phorbol ester-induced production of beta 2-immunoglobulin in B-CLL cells: relation to IgM secretory response and disease activity. British Journal of Haematology 1986; 62: 95–102
   PubMed Web of Science ®Google Scholar
• Dixon J., Kaklamanis L., Turley H., Hickson L. D., Leek R. D., Harris A. L., Gatter K. C. Expression of aminopeptidase-n (CD13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. Journal of Clinical Pathology 1994; 47: 43–47
   PubMed Web of Science ®Google Scholar
• Riopel M., Dickman P. S., Link M. P., Perlman E. J. MIC2 analysis in pediatric lymphomas and leukemias. Human Pathology 1994; 25: 396–399
   PubMed Web of Science ®Google Scholar
• De Melo N., Matutes E., Cordone I., Morilla R., Catovsky D. Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. Journal of Clinical Pathology 1992; 45: 660–663
   PubMed Web of Science ®Google Scholar
• Sabattini E., Gerdes J., Gherlinzoni F., Poggi S., Zucchini L., Melilli G., Grigoni F., del Vecchio M., Leoniani L., Falini B., Pileri S. A. Comparison between the monoclonal antibodies K-67 and PC10 in 125 malignant lymphomas. Journal of Pathology 1993; 169: 397–403
   PubMed Web of Science ®Google Scholar
• Wolowiec D., Benchaib M., Pernas P., Deviller P., Souchier C., Rimokh R., Felman P., Bayron P. A., French M. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 1995; 9: 1382–1388
   PubMed Web of Science ®Google Scholar
• Zwiebel J. A., Cheson B. D. Chronic lymphocytic leukemia: staging and prognostic factors. Seminars in Oncology 1998; 25: 42–59
   PubMed Web of Science ®Google Scholar